Sign in

or Register now

MultipleSclerosisCentral.com

    See all of our health sites at www.HealthCentral.com
    Saturday, November 21, 2009
    • Font size
    • Bookmark
    • Save
    Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

    Experimental MS drug may reduce relapses

    (Reuters) UPDATED 2009-09-21
    Drugmaker Opexa says their experimental drug Tovaxin helped 83 percent of patients with relapsing remitting multiple sclerosis remain relapse free after a year. The study of 150 patients found that the relapse rate among those who took the drug fell to 20 percent, which was 42 percent lower than those who took a placebo. The drugmaker says they plan to recruit more patients for another Phase II study on the medication.  Read full story >
    See all Multiple Sclerosis News
    • Font size
    • Bookmark
    • Was this helpful? Yes
    • Save

    People who read this also read...

      Note: All clinical content on this site is physician-reviewed, except material generated by our community members.
      Featuring Content From:
      • Harvard Health Publications
      • A.D.A.M.
      • Thomson PDR
      • Ivanhoe Broadcast News

      By using this service, you accept our Terms of Use. Please read them. The consumer health information on MultipleSclerosisCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

      This website is accredited by Health On the Net Foundation. Click to verify.We comply with the HONcode standard for trustworthy health information: verify here.
      • TRUSTe Certified Privacy
      • Health Care Standard of Excellence
      • FREDDIE International Health and Medical Media Award Finalist